Merit Medical [MMSI] vs Stevanato [STVN] Detailed Stock Comparison
Merit Medical
NASDAQ
Loading...
Stevanato
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Merit Medical wins in 9 metrics, Stevanato wins in 10 metrics, with 0 ties. Stevanato appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Merit Medical | Stevanato | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 43.44 | 41.46 | Stevanato |
| Price-to-Book Ratio | 3.41 | 4.62 | Merit Medical |
| Debt-to-Equity Ratio | 55.14 | 29.80 | Stevanato |
| PEG Ratio | 23.07 | 39.38 | Merit Medical |
| EV/EBITDA | 19.70 | 26.52 | Merit Medical |
| Profit Margin (TTM) | 8.31% | 11.75% | Stevanato |
| Operating Margin (TTM) | 12.30% | 15.03% | Stevanato |
| EBITDA Margin (TTM) | 12.30% | 15.03% | Stevanato |
| Return on Equity | 8.60% | 9.89% | Stevanato |
| Return on Assets (TTM) | 4.19% | 5.20% | Stevanato |
| Free Cash Flow (TTM) | $182.76M | $-157.80M | Merit Medical |
| 1-Year Return | -5.43% | 15.89% | Stevanato |
| Price-to-Sales Ratio (TTM) | 3.54 | 5.63 | Merit Medical |
| Enterprise Value | $5.55B | $7.87B | Stevanato |
| EV/Revenue Ratio | 3.87 | 5.91 | Merit Medical |
| Gross Profit Margin (TTM) | 48.24% | 28.06% | Merit Medical |
| Revenue per Share (TTM) | $24 | $4 | Merit Medical |
| Earnings per Share (Diluted) | $1.97 | $0.57 | Merit Medical |
| Beta (Stock Volatility) | 0.66 | 0.55 | Stevanato |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Merit Medical vs Stevanato Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Merit Medical | -0.08% | 0.94% | -10.24% | -10.94% | -22.14% | -10.92% |
| Stevanato | -2.36% | -5.93% | -3.67% | 5.12% | 10.78% | 5.59% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Merit Medical | -5.43% | 35.88% | 83.69% | 246.62% | 573.86% | 509.98% |
| Stevanato | 15.89% | 29.69% | 20.13% | 20.13% | 20.13% | 20.13% |
Performance & Financial Health Analysis: Merit Medical vs Stevanato
| Metric | MMSI | STVN |
|---|---|---|
| Market Information | ||
| Market Cap | $5.07B | $6.45B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 743,820 | 473,220 |
| 90 Day Avg. Volume | 745,243 | 340,687 |
| Last Close | $85.58 | $23.63 |
| 52 Week Range | $81.04 - $111.45 | $17.12 - $28.00 |
| % from 52W High | -23.21% | -15.61% |
| All-Time High | $111.45 (Jan 27, 2025) | $36.30 (Aug 07, 2023) |
| % from All-Time High | -23.21% | -34.90% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.08% |
| Quarterly Earnings Growth | -0.09% | 0.44% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.12% |
| Operating Margin (TTM) | 0.12% | 0.15% |
| Return on Equity (TTM) | 0.09% | 0.10% |
| Debt to Equity (MRQ) | 55.14 | 29.80 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $25.13 | $5.12 |
| Cash per Share (MRQ) | $5.77 | $0.38 |
| Operating Cash Flow (TTM) | $239.96M | $240.50M |
| Levered Free Cash Flow (TTM) | $190.72M | $-83,282,857 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Merit Medical vs Stevanato
| Metric | MMSI | STVN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 43.44 | 41.46 |
| Forward P/E | 23.07 | 39.38 |
| PEG Ratio | 23.07 | 39.38 |
| Price to Sales (TTM) | 3.54 | 5.63 |
| Price to Book (MRQ) | 3.41 | 4.62 |
| Market Capitalization | ||
| Market Capitalization | $5.07B | $6.45B |
| Enterprise Value | $5.55B | $7.87B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.87 | 5.91 |
| Enterprise to EBITDA | 19.70 | 26.52 |
| Risk & Other Metrics | ||
| Beta | 0.66 | 0.55 |
| Book Value per Share (MRQ) | $25.13 | $5.12 |
Financial Statements Comparison: Merit Medical vs Stevanato
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MMSI | STVN |
|---|---|---|
| Revenue/Sales | $355.35M | $256.60M |
| Cost of Goods Sold | $183.33M | $186.71M |
| Gross Profit | $172.02M | $69.89M |
| Research & Development | $22.48M | $5.93M |
| Operating Income (EBIT) | $42.06M | $34.63M |
| EBITDA | $77.83M | $55.55M |
| Pre-Tax Income | $37.96M | $35.11M |
| Income Tax | $7.81M | $8.60M |
| Net Income (Profit) | $30.15M | $26.51M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MMSI | STVN |
|---|---|---|
| Cash & Equivalents | $395.53M | $90.72M |
| Total Current Assets | $958.64M | $845.47M |
| Total Current Liabilities | $196.82M | $463.26M |
| Long-Term Debt | $808.22M | $312.73M |
| Total Shareholders Equity | $1.43B | $1.42B |
| Retained Earnings | $725.69M | $890.85M |
| Property, Plant & Equipment | $432.99M | $110.62M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MMSI | STVN |
|---|---|---|
| Operating Cash Flow | $57.24M | $100.69M |
| Capital Expenditures | N/A | $-69.33M |
| Free Cash Flow | $19.05M | $28.05M |
| Debt Repayment | $0 | $-55.75M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MMSI | STVN |
|---|---|---|
| Shares Short | 3.67M | 2.17M |
| Short Ratio | 6.49 | 7.35 |
| Short % of Float | 0.09% | 0.04% |
| Average Daily Volume (10 Day) | 743,820 | 473,220 |
| Average Daily Volume (90 Day) | 745,243 | 340,687 |
| Shares Outstanding | 58.74M | 272.90M |
| Float Shares | 57.82M | 48.89M |
| % Held by Insiders | 0.02% | 0.02% |
| % Held by Institutions | 1.09% | 1.10% |
Dividend Analysis & Yield Comparison: Merit Medical vs Stevanato
| Metric | MMSI | STVN |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.04 |
| 3-Year Avg Dividend Yield | N/A | 0.26% |
| 3-Year Total Dividends | N/A | $0.12 |
| Ex-Dividend Date | N/A | Jun 04, 2024 |